Executing to Plan

• First quarter executed on plan

  • First three 2004 corporate milestones achieved on schedule
  • 2004 cash guidance unchanged

• $200M raised in convertible debt offering

  • Preparing for two potential product launches

• Co-promote with Reliant Pharmaceuticals

  • Sustains existing relationships with endocrinologists and physicians

2004 Year to Date

Previous slide

Next slide

Back to first slide

View graphic version